miércoles, 22 de abril de 2020

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment By ADAM FEUERSTEIN AND MATTHEW HERPER

Go West

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

By ADAM FEUERSTEIN AND MATTHEW HERPER

GILEAD SCIENCES VIA AP
The outcomes in patients at a Chicago hospital offer only a snapshot of remdesivir’s effectiveness, but are the first clinical data to surface to date.

No hay comentarios: